Submitted by Anonymous (not verified) on 28 September 2023 - 12:16
Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Hepatitis D, Chronic, Date of authorisation: 31/07/2020, Revision: 11, Status: Authorised
Source: